AMBER MORTON: Open Payments
NPI 1811352321 · MARTINSVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$997 in 54 payments from 18 companies in 2025. Trend: 2023 $1,132 · 2024 $1,240 · 2025 $997
Food & beverage: $997
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $242 |
| ABBVIE INC. | 12 | $168 |
| PFIZER INC. | 4 | $77 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $61 |
| AstraZeneca Pharmaceuticals LP | 4 | $57 |
| Lilly USA, LLC | 3 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Astellas Pharma US Inc | 2 | $41 |
| Exact Sciences Corporation | 1 | $33 |
| Janssen Pharmaceuticals, Inc | 2 | $33 |
Products named: Ozempic, VRAYLAR, NURTEC ODT, XIFAXAN, QULIPTA, Rybelsus, Wegovy, TRINTELLIX.
Industry payments across VA — which companies pay providers there.
